Compare Amphastar Pharmaceuticals Inc (AMPH) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs PAGSEG Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while PAGSEG Inc trades at $8.91 (market cap $2.54B). The key difference: PAGSEG Inc is far larger — about 2.9× Amphastar Pharmaceuticals Inc's market cap, and PAGSEG Inc pays a 11.45% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | PAGS | |
|---|---|---|
Market Cap | $863.95M | $2.54B |
Sector | Health | Technology |
52-Week High | $30.81 | $12.00 |
52-Week Low | $16.87 | $8.38 |
Enterprise Value | $1.26B | $10.31B |
Dividend Yield | — | 11.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
PAGS trades at $9.14, down 2.35% on the day, with a bearish technical signal from moving averages but oversold RSI conditions. The stock shows strong fundamentals with a P/E of 6.31, net income margin of 10.4%, and positive cash flow. Recent earnings have been mixed, with a miss in Q1 2026 but a beat in Q4 2025, while analyst sentiment remains largely positive.
The outlook for PAGS is cautiously optimistic, supported by deep value metrics and a consensus price target of $11.45, implying significant upside. Risks include competitive pressures in financial services and sensitivity to Brazilian interest rates, but robust profitability and aggressive capital returns provide a buffer against near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
